title: Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations.
abstract: The molecular basis of more than 25 genetic diseases has been described in Ashkenazi Jewish populations. Most of these diseases are characterized by one or two major founder mutations that are present in the Ashkenazi population at elevated frequencies. One explanation for this preponderance of recessive diseases is accentuated genetic drift resulting from a series of dispersals to and within Europe, endogamy, and/or recent rapid population growth. However, a clear picture of the manner in which neutral genetic variation has been affected by such a demographic history has not yet emerged. We have examined a set of 32 binary markers (single nucleotide polymorphisms; SNPs) and 10 microsatellites on the non-recombining portion of the Y chromosome (NRY) to investigate the ways in which patterns of variation differ between Ashkenazi Jewish and their non-Jewish host populations in Europe. This set of SNPs defines a total of 20 NRY haplogroups in these populations, at least four of which are likely to have been part of the ancestral Ashkenazi gene pool in the Near East, and at least three of which may have introgressed to some degree into Ashkenazi populations after their dispersal to Europe. It is striking that whereas Ashkenazi populations are genetically more diverse at both the SNP and STR level compared with their European non-Jewish counterparts, they have greatly reduced within-haplogroup STR variability, especially in those founder haplogroups that migrated from the Near East. This contrasting pattern of diversity in Ashkenazi populations is evidence for a reduction in male effective population size, possibly resulting from a series of founder events and high rates of endogamy within Europe. This reduced effective population size may explain the high incidence of founder disease mutations despite overall high levels of NRY diversity.
authors.affiliation: Bruce Rappaport Faculty of Medicine and Research Institute, Technion and Rambam Medical Center, Haifa, Israel.
authors.forename: Doron M
authors.initials: DM
authors.lastname: Behar
authors.forename: Daniel
authors.initials: D
authors.lastname: Garrigan
authors.forename: Matthew E
authors.initials: ME
authors.lastname: Kaplan
authors.forename: Zahra
authors.initials: Z
authors.lastname: Mobasher
authors.forename: Dror
authors.initials: D
authors.lastname: Rosengarten
authors.forename: Tatiana M
authors.initials: TM
authors.lastname: Karafet
authors.forename: Lluis
authors.initials: L
authors.lastname: Quintana-Murci
authors.forename: Harry
authors.initials: H
authors.lastname: Ostrer
authors.forename: Karl
authors.initials: K
authors.lastname: Skorecki
authors.forename: Michael F
authors.initials: MF
authors.lastname: Hammer
mesh_terms: D041322:Chromosomes, Human, Y / Q000235:genetics*; D005060:Europe; D019143:Evolution, Molecular; D018703:Founder Effect; D005808:Genes, Recessive; D040961:Genetic Drift; D014644:Genetic Variation; D005828:Genetics, Population; D049690:History, Ancient; D006801:Humans; D007585:Jews / Q000235:genetics* / Q000266:history; D008297:Male; D020641:Polymorphism, Single Nucleotide; D020080:Tandem Repeat Sequences